Improving depression care together through innovation, education and practice 🧠" title="" class="btn" data-container="body" data-html="true" data-id="38992" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="The CAN-BIND Program"> 1,409 424
Activities
Entity types
Location
193 Yonge St, Toronto, ON M5B 1M4, Canada
Toronto
Canada
Employees
Scale: 51-200
Estimated: 9
Engaged catalyst
2Added in Motherbase
6 years agoImproving depression care together through innovation, education, and practice
The Canadian Biomarker Integration Network in Depression (CAN-BIND) is a national program of research and learning. Our community includes persons with lived experience, caregivers, researchers, healthcare providers, government agencies, industry partners, and mental health advocates who are working together to achieve mental wellness for all Canadians. CAN-BIND is discovering ways to identify the right treatment for the right person in order to help individuals with depression get well quickly, and stay well.
Our Vision: Improving depression care together through education, innovation and practice.
Our Mission: Our mission is to deliver fast and effective care to all Canadians living with depression. Through collaboration, research innovation and systems-oriented thinking, we seek to discover treatment strategies guided by each individual’s comprehensive history and pathway to depression.
Research, Education, Precision Medicine, PLE Engagement, Knowledge Exchange, Neuroimaging, Data Science, and Functional Genomics
The CAN-BIND study aims to take the guess work out of psychiatric treatment for depression, by finding clear and objective ways of matching the right treatment to the right patient for various types of depression.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 23 Nov 2018 | | |
![]() Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Oct 2014 | |